aTyr Pharma (FRA:471A) Other Current Liabilities : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is aTyr Pharma Other Current Liabilities?

aTyr Pharma's other current liabilities for the quarter that ended in Mar. 2024 was €0.00 Mil.

aTyr Pharma's quarterly other current liabilities declined from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil) but then increased from Dec. 2023 (€-0.00 Mil) to Mar. 2024 (€0.00 Mil).

aTyr Pharma's annual other current liabilities declined from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) and declined from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil).

aTyr Pharma Other Current Liabilities Historical Data

The historical data trend for aTyr Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aTyr Pharma Other Current Liabilities Chart

aTyr Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

aTyr Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

aTyr Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

aTyr Pharma Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of aTyr Pharma's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

aTyr Pharma (FRA:471A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » aTyr Pharma Inc (FRA:471A) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

LIFE:USA

Address

10240 Sorrento Valley Road, Suite 300, San Diego, CA, USA, 92121

Website

https://www.atyrpharma.com

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

aTyr Pharma (FRA:471A) Headlines

No Headlines